ilomastat has been researched along with hydroxyl radical in 1 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 10,147 | 26 | 3,657 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CF; Feng, NH; Lin, HI; Wang, D; Wang, NT; Yeh, DY | 1 |
1 other study(ies) available for ilomastat and hydroxyl radical
| Article | Year |
|---|---|
Matrix metalloprotease expressions in both reperfusion lung injury and oleic acid lung injury models and the protective effects of ilomastat.
Topics: Animals; Enzyme Inhibitors; Femoral Vein; Hydroxamic Acids; Hydroxyl Radical; Indoles; Leukocyte Count; Lung; Lung Injury; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Oleic Acid; Organ Size; Polymerase Chain Reaction; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; RNA, Messenger | 2009 |